Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Int J Gynaecol Obstet ; 162(1): 193-201, 2023 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-36495234

RESUMO

OBJECTIVE: To examine whether the early diagnosis of uterine incarceration before 20 weeks of gestation improves maternal-perinatal prognoses. METHODS: A systematic review of all of the cases published in the past 30 years that met the inclusion and exclusion criteria was performed and reported in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses recommendations. A comparative analysis of diagnoses before and after 20 weeks of gestation was performed. RESULTS: Eighty-nine studies with a total of 146 cases of uterine incarceration during pregnancy were included. For cases of incarceration diagnosed before 20 weeks of gestation, a higher proportion of clinical symptoms was observed; however, a lower proportion of complications, such as premature delivery, need for cesarean section, and poor perinatal outcomes, were observed (P < 0.05). The proportion of spontaneous resolution and minimally invasive techniques for the treatment of incarceration was significantly higher among patients diagnosed with this pathology before 20 weeks (P < 0.05). CONCLUSION: The literature indicates that uterine incarceration is a rare complication during pregnancy with better maternal-perinatal results if diagnosed earlier than 20 weeks.


Assuntos
Complicações na Gravidez , Doenças Uterinas , Gravidez , Humanos , Feminino , Cesárea , Doenças Uterinas/diagnóstico , Útero , Complicações na Gravidez/diagnóstico , Diagnóstico Precoce
2.
Clin Case Rep ; 10(2): e05484, 2022 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-35223025

RESUMO

We present a rare case of mirror syndrome due to anti-Kpa antibodies, which can be difficult to identify with routine screening tests.

3.
Artigo em Inglês | MEDLINE | ID: mdl-34831539

RESUMO

Preeclampsia is one of the most worrisome complications during pregnancy, affecting approximately 1 out of 20 women worldwide. Preeclampsia is mainly characterized by a sustained hypertension, proteinuria, also involving a significant organ dysfunction. Moreover, 25% of the cases could be classified as severe preeclampsia (SP), a serious condition that could be life-threatening for both the mother and fetus. Although there are many studies focusing on preeclampsia, less efforts have been made in SP, frequently limited to some specific situations. Thus, the present study aims to conduct a comparative analysis of risk factors, maternal characteristics, obstetric and neonatal outcomes and maternal complications in patients with severe preeclampsia versus patients without severe preeclampsia. Hence, 235 cases and 470 controls were evaluated and followed in our study. We described a set of variables related to the development of severe preeclampsia, including maternal age > 35 years (69.8%), gestational (26.8%) or chronic arterial hypertension (18.3%), obesity (22.6%), use of assisted reproduction techniques (12.3%), prior history of preeclampsia (10.2%) and chronic kidney disease (7.7%) All patients had severe hypertension (>160 mmHg) and some of them presented with additional complications, such as acute renal failure (51 cases), HELLP syndrome (22 cases), eclampsia (9 cases) and acute cerebrovascular accidents (3 cases). No case of maternal death was recorded, although the SP group had a higher cesarean section rate than the control group (60% vs. 20.9%) (p < 0.001), and there was a notably higher perinatal morbidity and mortality in these patients, who had a prematurity rate of 58.3% (p < 0.001) and 14 perinatal deaths, compared to 1 in the control group. Overall, our study recognized a series of factors related to the development of SP and related complications, which may be of great aid for improving the clinical management of this condition.


Assuntos
Eclampsia , Pré-Eclâmpsia , Adulto , Estudos de Casos e Controles , Cesárea , Estudos de Coortes , Feminino , Humanos , Recém-Nascido , Pré-Eclâmpsia/epidemiologia , Gravidez , Resultado da Gravidez/epidemiologia
4.
J Matern Fetal Neonatal Med ; 33(14): 2493-2504, 2020 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-30652519

RESUMO

Early onset Marfan syndrome is the most severe form of Marfan syndrome diagnosed during perinatal period. Early onset Marfan syndrome is associated with high mortality rates, usually within the first 2 years of life. First, we present a case of prenatally diagnosed early onset Marfan syndrome in a dichorionic diamniotic twin pregnancy, where suspicion was raised at 35 weeks of gestation. Ultrasound and fetal magnetic resonance imaging were used to assess prenatal findings in the affected fetus. She presented right diaphragmatic eventration, elongation of humerus and femur and subluxation of the crystalline lens. She died 3 months after birth. Secondly, we present a PubMed-based review of the published articles on early onset Marfan syndrome, with pre- or postnatal suspicion or diagnosis. We found 39 articles published between 1981 and 2017, arising information on 55 cases. Including ours, early onset Marfan syndrome was prenatally diagnosed in 34.54% of the cases. In these cases, the most frequent prenatal findings were cardiomegaly, dilatation of the great vessels and mitral or tricuspid regurgitation. Mortality rate during the first 15 months after birth was 73.68%. In the postnatally diagnosed cases, the most frequent findings were arachnodactyly, dilatation of the great vessels and mitral or tricuspid regurgitation. Mortality rate was 61.11%. Overall genetic confirmation was performed in 67.27% of the cases. Prenatal diagnosis of early onset Marfan syndrome is challenging but of utmost importance, since management should take place in a tertiary care center, by a multidisciplinary team. Differential diagnosis is essential in order to perform an adequate genetic counseling.


Assuntos
Síndrome de Marfan/diagnóstico , Ultrassonografia Pré-Natal/métodos , Adulto , Ecocardiografia , Evolução Fatal , Feminino , Idade Gestacional , Humanos , Lactente , Recém-Nascido , Imageamento por Ressonância Magnética , Síndrome de Marfan/mortalidade , Síndrome de Marfan/patologia , Gravidez , Gravidez de Gêmeos
5.
Clin Case Rep ; 5(4): 449-453, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28396767

RESUMO

Bardet-Biedl syndrome (BBS) is a ciliopathy that is responsible for multiple visceral abnormalities. This disorder is defined by a combination of clinical signs, many of which appear after several years of development. BBS may be suspected antenatally based on routine ultrasound findings of enlarged hyperechogenic kidneys and postaxial polydactyly.

6.
Prog. obstet. ginecol. (Ed. impr.) ; 49(9): 532-536, sept. 2006. ilus
Artigo em Es | IBECS | ID: ibc-048491

RESUMO

La gigantomastia, o hipertrofia mamaria masiva, es una entidad muy rara de etiología desconocida, que quizás se deba a una estimulación hormonal excesiva o a una hipersensibilidad del órgano diana. El tratamiento durante el embarazo es de soporte y farmacológico. En el posparto la mayoría de las pacientes requiere una reducción mamaria y una reconstrucción quirúrgica. Presentamos el caso de una paciente con un rápido crecimiento mamario bilateral durante el embarazo, a la que se tuvo que realizar una cesárea en la semana 32 de gestación por el gran riesgo materno que suponía mantener el embarazo. En un segundo tiempo se realizó una reducción mamaria bilateral


Gigantomastia, or massive breast hypertrophy, is a rare condition of unknown etiology that may be due to hormonal overproduction or hypersensitivity of the target organ. Treatment during pregnancy is supportive and pharmacologic. Most patients require reduction mammoplasty. We present the case of a patient with rapid and massive bilateral breast enlargement during pregnancy. Premature labour at 32 weeks was followed by delivery of a normal infant by caesarean section. In a second intervention, a reduction mammoplasty was carried out


Assuntos
Feminino , Gravidez , Adulto , Humanos , Mastite/complicações , Complicações na Gravidez , Hipertrofia/complicações , Mastite/cirurgia , Cesárea , Bromocriptina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...